Brignole M, Gaggioli G, Menozzi C, Del Rosso A, Costa S, Bartoletti A, Bottoni N, Lolli G
Arrhythmologic Centre, Ospedali Riuniti, Lavagna, Italy.
Heart. 2000 Jan;83(1):24-8. doi: 10.1136/heart.83.1.24.
To evaluate the possible relation between adenosine sensitive syncope and tilt induced vasovagal syncope.
An ATP test and a head up tilt test were performed in 175 consecutive patients with syncope of uncertain origin. The ATP test consisted of the rapid intravenous injection of 20 mg of ATP; a positive response was defined as the induction of a ventricular pause (maximum RR interval) >/= 6000 ms. The head up tilt test was performed at 60 degrees for 45 minutes; if negative, 0.4 mg oral glyceryl trinitrate spray was given and the test continued for a further 20 minutes; a positive response was defined as induction of syncope in the presence of bradycardia, hypotension, or both.
Of the 121 patients with a positive response, 77 (64%) had a positive head up tilt alone, 18 (15%) had a positive ATP test alone, and in 26 (21%) both ATP and head up tilt were positive. Compared with the patients with isolated positive head up tilt, those with isolated positive ATP were older (mean (SD) age, 68 (10) v 45 (20) years), had a lower median number of syncopal episodes (2 v 3), a shorter median duration of syncopal episodes (4 v 36 months), a lower prevalence of situational, vasovagal, or triggering factors (11% v 64%), a lower prevalence of warning symptoms (44% v 71%), and a higher prevalence of systemic hypertension (22% v 5%) and ECG abnormalities (28% v 9%). The patients with a positive response to both tests had intermediate features. Of the 44 positive responses to the ATP test, atrioventricular block was the cause of the ventricular pause in 43; of the 29 positive cardioinhibitory responses to head up tilt, sinus arrest was present in 23 cases and atrioventricular block in six.
ATP and head up tilt tests identify different populations of patients affected by syncope; these have different general clinical features, different histories of syncopal episodes, and different mechanism sites of action. Therefore, adenosine sensitive syncope and tilt induced vasovagal syncope are two distinct clinical entities.
评估腺苷敏感性晕厥与倾斜试验诱发的血管迷走性晕厥之间的可能关系。
对175例连续的不明原因晕厥患者进行了ATP试验和直立倾斜试验。ATP试验包括快速静脉注射20mg ATP;阳性反应定义为诱发心室停搏(最大RR间期)≥6000毫秒。直立倾斜试验在60度下进行45分钟;若为阴性,则给予0.4mg口服硝酸甘油喷雾剂,并继续试验20分钟;阳性反应定义为在出现心动过缓、低血压或两者并存的情况下诱发晕厥。
在121例阳性反应患者中,77例(64%)仅直立倾斜试验阳性,18例(15%)仅ATP试验阳性,26例(21%)ATP试验和直立倾斜试验均阳性。与单纯直立倾斜试验阳性的患者相比,单纯ATP试验阳性的患者年龄更大(平均(标准差)年龄,68(1)岁对45(20)岁),晕厥发作的中位数次数更低(2次对3次),晕厥发作的持续时间中位数更短(4个月对36个月),情境性、血管迷走性或触发因素的患病率更低(11%对64%),预警症状的患病率更低(44%对71%),系统性高血压的患病率更高(22%对5%)以及心电图异常的患病率更高(28%对9%)。两项试验均阳性反应的患者具有中间特征。在44例ATP试验阳性反应中,43例心室停搏的原因是房室传导阻滞;在29例直立倾斜试验的阳性心脏抑制反应中,23例出现窦性停搏,6例出现房室传导阻滞。
ATP试验和直立倾斜试验识别出受晕厥影响的不同患者群体;这些群体具有不同的一般临床特征、不同的晕厥发作病史以及不同的作用机制部位。因此,腺苷敏感性晕厥和倾斜试验诱发的血管迷走性晕厥是两种不同的临床实体。